El levonorgestrel y su mecanismo de acción
DOI:
https://doi.org/10.11565/arsmed.v31i1.288Resumen
Sin resumen disponibleDescargas
Citas
Ver Glasier, A., “Emergency Postcoital Contraceptionâ€, The New England Journal of Medicine 337
(1997): 1058.
Ver Tabibzadeh, S., Babaknia, A. “The Signals and Molecular Pathways Involved in
Implantation, a Symbiotic Interaction between Blastocyst and Endometrium Involving
Adhesion and Tissue Invasionâ€, Human Reproduction 10 (1995): 1579-1602; J. C. Cross, Z.
Werb, and S. J. Fisher, “Implantation and the Placenta: Key Pieces of the Development
Puzzle,†Science, 266 (1994): 1508-1518, pp. 1510-1513; B. A. Lessey, “The Role of the
Endometrium During Embryo Implantationâ€, Human Reproduction Suppl. 6 (2000): 39-50.
Ver Kimber, S. J., “molecular Interactions at the Maternal-Embryonic Interface During the
Early Phase of Implantationâ€, Seminars Reproductive Medicine 18 (2000): 91-96; M. Thie,
R. Rospel, W. Dettmann, M. Benoit, M. Ludwig, H. E. Gaub, H. W. Denker, “Interactions
between Trophoblast and Uterine Epithelium: Monitoring of Adhesive Forcesâ€, Human
Reproduction 13 (1998): 3211-3219. 4 Cross, J. C., Werb, Z., and Fisher, S. J., “Implantation
and the Placenta: Key Pieces of the Development Puzzle,†Science, 266 (1994): 1508-1518,
pp. 1514-1516. 50 Eduardo Rodríguez Yunta
Ver Sharkey M.; Dellow, K.; Blayney M.; Macnamee M.; Charnock-Jones S.; Smith S. K.,
“Stage- Specific Expression of Cytokine and Receptor Messenger Ribonucleic Acids in
Human Preimplantation Embryosâ€, Biological Reproduction 53 (1995): 974-981.
Ver Hansis, C.; Grifo, J. A.; Krey L. C., “Oct.-4 Expression in Inner Cell Mass and
Trophoectoderm of Human Blastocystsâ€, Molecular Human Reproduction 6 (2000): 999-
Ver Adjaye, J.; Daniels, R.; Monk, M., “The Construction of cDNA Libraries from Human
Single Preimplantation Embryos and their Use in the Study of Gene Expression during
Developmentâ€, Journal of Assisted Reproduction Genetics 15 (1998): 344-348; R. Daniels,
S. Lowell, V. Bolton, M. Monk, “Transcription of Tissue-Specific Genes in Human
Preimplantation Embryosâ€, Human Reproduction 12 (1997): 2251-2256.
Ver Ao, A.; Erickson, R. P. ;Winston, R. M.; Handyside, A. H. “Transcription of Paternal
Y-Linked Genes in the Human Zygote as Early as the Pronucleate Stageâ€,
American College of Obstetrics and Ginecology, Obstetric-Ginecology Terminology
(1972).
Ver Tatum, H. J.; Connell, E. B., “A Decade of Intrauterine Contraception: 1976 to
â€, Fertility and Sterility 46 (1986): 186.
Decreto 873 Ministerio de Relaciones Exteriores (1991).
Ho, P. C., y Kwan, M. S. W., “A Prospective Randomized Comparison of Levonorgestrel
with the Yuzpe Regimen in Post-coital Contraceptionâ€, Human Reproduction 8 (1995): 389-
; World Health Organization, “Randomized Controlled Trial of Levonorgestrel versus the
Yuzpe Regimen of Combined Oral Contraceptives for Emergency Contraceptionâ€, The
Lancet 352 (1998): 428-433.
Ver United Nations Development Programme/ United Nations Population Fund/ World
Health Organization/ World Bank Special Programme of Research Training in Human
Reproduction, Task Force on Post-Ovulatory Methods of Fertility Regulation. “Eficacy and
side Effects of Immediate Postcoital Levonorgestrel Used Repeatedly for Contraceptionâ€,
Contraception 61 (2000): 303-308.
Ver Rodríguez-Manzaneque, J. C., Graubert, M.; Iruela-Arispe, M. L.; “Endothelial Cell
Dysfunction Following Prolonged Activation of Progesterone Receptorâ€, Human
Reproduction Suppl 3 (2000): 39-47; Vincent, A. J., Salamonsen, L. A., “The Role of Matrix
Metalloproteinases and Leukocytes in Abnormal Uterine Bleeding Associated with
Progestin-only Contraceptivesâ€, Human Reproduction Suppl 3 (2000): 135-143.
Ver Glasier, A., “Emergency Postcoital Contraceptionâ€, The New England Journal of
Medicine 337 (1997): 1058- 1064.
Ver von Hertzen, H., y Van Look, P. F. A., “Research on New Methods of Emergency
Contraceptionâ€, International Family Planning Perspectives 22 (1996): 62-68.
Ver Heikinheimo O., Gordon, K., Williams, R. F., Hodgen, G. D., “Inhibition of
Ovulation by Progestin Analogs (Agonist vs Antagonists). Preliminary Evidence for
Different Sites and Mechanism of Actionsâ€, Contraception 53 (1996): 55-64.
Ver Contreras, H. R., Llanos, M. N., “Detection of Progesterone Receptors in Human
Spermatozoa and their Correlation with Morphological and Functional Propertiesâ€,
International Journal of Andrology 24 (2001): 246-252.
Ver Dunson, T. R., Blumenthal, P. D., Alvarez, F., Bracke, V., Cochon, L., Dalberth, B.,
Glover, L., Remsburg, R., Vu, K., Katz, D., “Timing of Onset of Contraceptive Effectiveness
in Norplant Implant Users. Part I. Changes in cervical Mucusâ€, Fertility Sterility 69 (1998):
-266.
Ver von Hertzen, H., y Van Look, P. F. A., “Research on New Methods of Emergency
Contraceptionâ€, International Family Planning Perspectives 22 (1996): 62-68.
Ver Telleria, C. M., Carrizo, D. G., Deis, R. P., “Levonorgestrel Inhibits Luteinizing
Hormonestimulated Progesterone Production in Rat Luteal Cellsâ€, Journal of Steroid
Biochemical Molecular Biology 50 (1994): 161-166.
Ver Landgren, B. M., Johannisson, E., Aedo, A. R., Kumar, A., Shi, Y. E., “The Effect of
Levonorgestrel Administered in Large Doses at Different Stages of the Cycle on ovarian
Function and Endometrial Morphologyâ€, Contraception 39 (1989):275-289; Wang, J. D. Wu
J. C. Proceeding of the International Conference on Reproductive Health (1998, Mursbai,
India): 15-19.
Ver Pakarinen, P. I., Lahteemaki, P., Lehtonen, E., Reima I., “The Ultraestructure of
Human Endometrium is Altered by Administration of Intrauterine Levonorgestrelâ€, Human
Reproduction 13 (1998): 1846-1853.
Ver Swahn, M. L., Westlund, P., Johannisson, E., Bygdeman, M., “Effect of Post-coital
Contraceptive Methods on the Endometrium and the Menstrual Cycleâ€, Acta Obstetrics
Gynecology Scandinavian 75 (1996): 738-744.
Ver Hapangama, D., Glasier, A. F., Baird, D. T., “The Effects of Peri-ovulatory
Administration of Levonorgestrel on the Menstrual Cycleâ€, Contraception 63 (2001): 123-
Ver Wilcox, A. J., “Incidence of Early Loss of Pregnancy,†New England Journal of
Medicine 319 (1988): 189-194.
Ver Gillebaud, J., “Time for Emergengy Contraception with Levonorgestrel Aloneâ€,
Lancet 352 (1998): 416-417; World Health Organization, “Randomized Controlled Trial of
Levonorgestrel versus the Yuzpe Regimen of Combined Oral Contraceptives for Emergency
Contraceptionâ€, The Lancet 352 (1998): 428-433.
Ver von Hertzen, H., y Van Look, P. F. A., “Research on New Methods of Emergency
Contraceptionâ€, International Family Planning Perspectives 22 (1996): 62-68.
Ver Lemus, A. E., Vilchis, F., Damsky, R., Chávez, B. A., García, G. A., Grillasca, I.,
Pérez- Palacios, G., “Mechanism of Action of Levonorgestrel: In Vitro Metabolism and
Specific Interactions with Steroid Receptors in Target Organsâ€, Journal Steroid Biochemical
Molecular Biology 41 (1992): 881-890.
Ver Telleria, C.M., Carrizo, D.G., Deis R.P. “Levonorgestrel inhibits luteinizing hormone
- stimulated progesterone production in rat luteal cellâ€. Journal of Steroid Biochemistry
Molecular Biology 50 (1994) = 161-166.
Ver Von Look, P. F. A., von Hertzen, H., “Emergency Contraceptionâ€, British Medical
Bulletin 49 (1993): 158-170.
Ver Chabbert Buffet, N., Djakoure, C., Maitre, S. C., Bouchard, P., “Regulation of the
Human Menstrual Cycleâ€, Neuroendocrinology 19 (1998): 151-186, Mahesh, V. B., Brann,
D. W., Hendry, L. B., “Diverse Modes of Action of Progesterone and its Metabolitesâ€,
Journal of Steroid Biochemical Molecular Biology 56 (1996): 209-219
Ver Patrat, C., Serres C., Jouannet, P., “The Acrosome Reaction in Human Spermatozoaâ€,
Biol. Cell 92 (2000): 255-266.
Ver Nikas, G., “Endometrial Receptivity: Changes in Cell-Surface Morphologyâ€,
Seminars Reproductive Medicine 18 (2000): 229-235.
Ver Fan, X. G., Zheng, Z. Q., “A Study of Early Pregnancy Factor Activity in
Preimplantationâ€, American Journal Reproductive Inmunology 37 (1997): 359-364.
Ver Cavanagh, A. C., “Identification of Early Pregnancy Factor as Chaperonin 10:
Implications for Understanding its Roleâ€, Review Reproduction 1 (1996): 28-32.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2016 ARS MEDICA Revista de Ciencias Médicas
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
A partir del 1 de octubre 2023, los autores/as conservan sus derechos de autor y garantizan a la revista el derecho de primera publicación de su obra, la que estará simultáneamente sujeta a la Licencia CC BY-SA 4.0 (Ver declaración de Acceso Abierto).
